Burden of disease and cost of illness of atrial fibrillation in Portugal Miguel Gouveia, João Costa, Joana Alarcão, Margarida Augusto, Daniel Caldeira, Luís Pinheiro, António Vaz Carneiro, Margarida Borges

Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting João Morais, Carlos Aguiar, Euan McLeod, Ismini Chatzitheofilou, Isabel Fonseca Santos, Sónia Pereira

Atrial fibrillation monitoring to reduce thromboembolic risk: Selecting the patient and the monitoring device Sérgio Barra, Rui Providência